{"DataElement":{"publicId":"3451636","version":"1","preferredName":"Vaginal Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer of the vagina.","longName":"3448119v1.0:3449340v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3448119","version":"1","preferredName":"Vaginal Neoplasm Stage Grouping","preferredDefinition":"Relating to the vagina or to any sheath._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2451452v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2451452","version":"1","preferredName":"Vaginal Neoplasm","preferredDefinition":"Relating to the vagina or to any sheath.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C13309:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal","conceptCode":"C13309","definition":"Of or relating to the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C625C4B-28DD-27E6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-15","modifiedBy":"ONEDATA","dateModified":"2006-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2B7D-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3449340","version":"1","preferredName":"Vaginal Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A term that refers to the staging of vaginal carcinoma according to the American Joint Committee on Cancer, 7th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3449340v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B402-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Vaginal Cancer","ValueMeaning":{"publicId":"3449342","version":"1","preferredName":"Stage 0 Vaginal Cancer","longName":"3449342","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis.  M0: No distant metastasis.  FIGO no longer includes stage 0. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Vaginal Cancer AJCC v7","conceptCode":"C89476","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis.  M0: No distant metastasis.  FIGO no longer includes stage 0. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B40F-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B428-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Vaginal Cancer","ValueMeaning":{"publicId":"3449344","version":"1","preferredName":"Stage I Vaginal Cancer","longName":"3449344","preferredDefinition":"Stage I includes: (T1, N0, M0).  T1: Tumor confined to vagina.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Vaginal Cancer AJCC v6 and v7","conceptCode":"C7856","definition":"Stage I includes: (T1, N0, M0).  T1: Tumor confined to vagina.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B435-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B44E-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Vaginal Cancer","ValueMeaning":{"publicId":"3449346","version":"1","preferredName":"Stage II Vaginal Cancer","longName":"3449346","preferredDefinition":"Stage II includes: T2, N0, M0. T2: Tumor invades paravaginal tissues but not to pelvic wall.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Vaginal Cancer AJCC v6 and v7","conceptCode":"C7857","definition":"Stage II includes: T2, N0, M0. T2: Tumor invades paravaginal tissues but not to pelvic wall.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B45B-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B474-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Vaginal Cancer","ValueMeaning":{"publicId":"3449348","version":"1","preferredName":"Stage III Vaginal Cancer","longName":"3449348","preferredDefinition":"Stage III includes: (T1-3, N1, M0) and (T3, N0, M0). T1: Tumor confined to vagina.  T2: Tumor invades paravaginal tissues but not to pelvic wall.  T3: Tumor extends to pelvic wall.  N0: No regional lymph node metastasis.  N1: Pelvic or inguinal lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Vaginal Cancer AJCC v6 and v7","conceptCode":"C7858","definition":"Stage III includes: (T1-3, N1, M0) and (T3, N0, M0). T1: Tumor confined to vagina.  T2: Tumor invades paravaginal tissues but not to pelvic wall.  T3: Tumor extends to pelvic wall.  N0: No regional lymph node metastasis.  N1: Pelvic or inguinal lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B481-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B49A-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Vaginal Cancer","ValueMeaning":{"publicId":"3449350","version":"1","preferredName":"Stage IVA Vaginal Cancer","longName":"3449350","preferredDefinition":"Stage IVA includes: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4).  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Vaginal Cancer AJCC v6 and v7","conceptCode":"C7859","definition":"Stage IVA includes: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4).  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B4A7-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B4C0-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Vaginal Cancer","ValueMeaning":{"publicId":"3449352","version":"1","preferredName":"Stage IVB Vaginal Cancer","longName":"3449352","preferredDefinition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Vaginal Cancer AJCC v6 and v7","conceptCode":"C9355","definition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B4CD-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF2A2EDD-B4E6-258B-E040-BB89AD430670","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3449339","version":"1","preferredName":"Vaginal Carcinoma by AJCC v7 Stage Stage Grouping Stage","preferredDefinition":"No Value Exists:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C91204:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer by AJCC v7 Stage","conceptCode":"C91204","definition":"A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 7th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B3D9-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B3EA-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3447901","version":"1","longName":"Vagina","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777532","version":"1","longName":"Vaginal","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BF7277D4-0DB7-119F-E040-BB89AD432732","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}